Cargando…
Enhanced recovery after surgery in transurethral surgery for benign prostatic hyperplasia
Enhanced recovery after surgery (ERAS) measures have not been systematically applied in transurethral surgery for benign prostatic hyperplasia (BPH). This study was performed on patients with BPH who required surgical intervention. From July 2019 to June 2020, the ERAS program was applied to 248 pat...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226510/ https://www.ncbi.nlm.nih.gov/pubmed/36254889 http://dx.doi.org/10.4103/aja202267 |
_version_ | 1785050591829950464 |
---|---|
author | Zhou, Jing Peng, Zhu-Feng Song, Pan Yang, Lu-Chen Liu, Zheng-Huan Shi, Shuai-Ke Wang, Lin-Chun Chen, Jun-Hao Liu, Liang-Ren Dong, Qiang |
author_facet | Zhou, Jing Peng, Zhu-Feng Song, Pan Yang, Lu-Chen Liu, Zheng-Huan Shi, Shuai-Ke Wang, Lin-Chun Chen, Jun-Hao Liu, Liang-Ren Dong, Qiang |
author_sort | Zhou, Jing |
collection | PubMed |
description | Enhanced recovery after surgery (ERAS) measures have not been systematically applied in transurethral surgery for benign prostatic hyperplasia (BPH). This study was performed on patients with BPH who required surgical intervention. From July 2019 to June 2020, the ERAS program was applied to 248 patients, and the conventional program was applied to 238 patients. After 1 year of follow-up, the differences between the ERAS group and the conventional group were evaluated. The ERAS group had a shorter time of urinary catheterization compared with the conventional group (mean ± standard deviation [s.d.]: 1.0 ± 0.4 days vs 2.7 ± 0.8 days, P < 0.01), and the pain (mean ± s.d.) was significantly reduced through postoperative hospitalization days (PODs) 0–2 (POD 0: 1.7 ± 0.8 vs 2.4 ± 1.0, P < 0.01; POD 1: 1.6 ± 0.9 vs 3.5 ± 1.3, P < 0.01; POD 2: 1.2 ± 0.7 vs 3.0 ± 1.3, P < 0.01). No statistically significant difference was found in the rate of postoperative complications, such as postoperative bleeding (P = 0.79), urinary retention (P = 0.40), fever (P = 0.55), and readmission (P = 0.71). The hospitalization cost of the ERAS group was similar to that of the conventional group (mean ± s.d.: 16 927.8 ± 5808.1 Chinese Yuan [CNY] vs 17 044.1 ± 5830.7 CNY, P =0.85). The International Prostate Symptom Scores (IPSS) and quality of life (QoL) scores in the two groups were also similar when compared at 1 month, 3 months, 6 months, and 12 months after discharge. The ERAS program we conducted was safe, repeatable, and efficient. In conclusion, patients undergoing the ERAS program experienced less postoperative stress than those undergoing the conventional program. |
format | Online Article Text |
id | pubmed-10226510 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-102265102023-05-30 Enhanced recovery after surgery in transurethral surgery for benign prostatic hyperplasia Zhou, Jing Peng, Zhu-Feng Song, Pan Yang, Lu-Chen Liu, Zheng-Huan Shi, Shuai-Ke Wang, Lin-Chun Chen, Jun-Hao Liu, Liang-Ren Dong, Qiang Asian J Androl Original Article Enhanced recovery after surgery (ERAS) measures have not been systematically applied in transurethral surgery for benign prostatic hyperplasia (BPH). This study was performed on patients with BPH who required surgical intervention. From July 2019 to June 2020, the ERAS program was applied to 248 patients, and the conventional program was applied to 238 patients. After 1 year of follow-up, the differences between the ERAS group and the conventional group were evaluated. The ERAS group had a shorter time of urinary catheterization compared with the conventional group (mean ± standard deviation [s.d.]: 1.0 ± 0.4 days vs 2.7 ± 0.8 days, P < 0.01), and the pain (mean ± s.d.) was significantly reduced through postoperative hospitalization days (PODs) 0–2 (POD 0: 1.7 ± 0.8 vs 2.4 ± 1.0, P < 0.01; POD 1: 1.6 ± 0.9 vs 3.5 ± 1.3, P < 0.01; POD 2: 1.2 ± 0.7 vs 3.0 ± 1.3, P < 0.01). No statistically significant difference was found in the rate of postoperative complications, such as postoperative bleeding (P = 0.79), urinary retention (P = 0.40), fever (P = 0.55), and readmission (P = 0.71). The hospitalization cost of the ERAS group was similar to that of the conventional group (mean ± s.d.: 16 927.8 ± 5808.1 Chinese Yuan [CNY] vs 17 044.1 ± 5830.7 CNY, P =0.85). The International Prostate Symptom Scores (IPSS) and quality of life (QoL) scores in the two groups were also similar when compared at 1 month, 3 months, 6 months, and 12 months after discharge. The ERAS program we conducted was safe, repeatable, and efficient. In conclusion, patients undergoing the ERAS program experienced less postoperative stress than those undergoing the conventional program. Wolters Kluwer - Medknow 2022-10-11 /pmc/articles/PMC10226510/ /pubmed/36254889 http://dx.doi.org/10.4103/aja202267 Text en Copyright: © The Author(s)(2022) https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Zhou, Jing Peng, Zhu-Feng Song, Pan Yang, Lu-Chen Liu, Zheng-Huan Shi, Shuai-Ke Wang, Lin-Chun Chen, Jun-Hao Liu, Liang-Ren Dong, Qiang Enhanced recovery after surgery in transurethral surgery for benign prostatic hyperplasia |
title | Enhanced recovery after surgery in transurethral surgery for benign prostatic hyperplasia |
title_full | Enhanced recovery after surgery in transurethral surgery for benign prostatic hyperplasia |
title_fullStr | Enhanced recovery after surgery in transurethral surgery for benign prostatic hyperplasia |
title_full_unstemmed | Enhanced recovery after surgery in transurethral surgery for benign prostatic hyperplasia |
title_short | Enhanced recovery after surgery in transurethral surgery for benign prostatic hyperplasia |
title_sort | enhanced recovery after surgery in transurethral surgery for benign prostatic hyperplasia |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226510/ https://www.ncbi.nlm.nih.gov/pubmed/36254889 http://dx.doi.org/10.4103/aja202267 |
work_keys_str_mv | AT zhoujing enhancedrecoveryaftersurgeryintransurethralsurgeryforbenignprostatichyperplasia AT pengzhufeng enhancedrecoveryaftersurgeryintransurethralsurgeryforbenignprostatichyperplasia AT songpan enhancedrecoveryaftersurgeryintransurethralsurgeryforbenignprostatichyperplasia AT yangluchen enhancedrecoveryaftersurgeryintransurethralsurgeryforbenignprostatichyperplasia AT liuzhenghuan enhancedrecoveryaftersurgeryintransurethralsurgeryforbenignprostatichyperplasia AT shishuaike enhancedrecoveryaftersurgeryintransurethralsurgeryforbenignprostatichyperplasia AT wanglinchun enhancedrecoveryaftersurgeryintransurethralsurgeryforbenignprostatichyperplasia AT chenjunhao enhancedrecoveryaftersurgeryintransurethralsurgeryforbenignprostatichyperplasia AT liuliangren enhancedrecoveryaftersurgeryintransurethralsurgeryforbenignprostatichyperplasia AT dongqiang enhancedrecoveryaftersurgeryintransurethralsurgeryforbenignprostatichyperplasia |